ZNF226
protein-codingzinc finger protein 226, the group of Zinc fingers C2H2-type
Gene summary
Predicted to enable transcription cis-regulatory region binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~13.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZNF226 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001032373.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 131 | 8 | 139 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 133 | 8 | 0 | 141 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001027545.1 | 4 | MANE Select | |
| Ensembl | ENSP00000336719.5 | 4 | MANE Select | |
| RefSeq | NP_001027544.1 | 4 | Standard | |
| RefSeq | NP_001027546.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gene expression (Transcription)
- Generic Transcription Pathway
- RNA Polymerase II Transcription
Biological Process
- regulation of transcription by RNA polymerase II
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- metal ion binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000590089
- Coding exons
- 4
- Length
- 13309
- Individuals with no LoFs
- 125337
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 410
- Defined
- 125748
- p
- 0.00164
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.833 | 465 | 417 | 1.11 | 0.0000202 | 5364 |
| Missense (PolyPhen) | 195 | 167.21 | 1.1662 | 2182 | ||
| Synonymous | -1.29 | 165 | 145 | 1.14 | 0.00000700 | 1388 |
| Loss of Function | 0.867 | 25 | 30.1 | 0.830 | 0.00000154 | 411 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0011 | 0.0010 | notable |
| Latino/Admixed American | 0.0019 | 0.0011 | notable |
| Ashkenazi Jewish | 0.00050 | 0.00050 | rare |
| East Asian | 0.0061 | 0.0060 | notable |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00094 | 0.00090 | rare |
| South Asian | 0.0045 | 0.0045 | notable |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in transcriptional regulation.;
Intolerance Scores
- LoFtool
- 0.983
- RVIS EVS
- -0.42
- RVIS percentile EVS
- 25.83
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.755
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |